KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Capital Expenditures (2016 - 2025)

Insulet's Capital Expenditures history spans 16 years, with the latest figure at -$37.3 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 169.59% year-over-year to -$37.3 million; the TTM value through Dec 2025 reached $19.2 million, down 84.63%, while the annual FY2025 figure was $19.2 million, 84.63% down from the prior year.
  • Capital Expenditures reached -$37.3 million in Q4 2025 per PODD's latest filing, down from $48.5 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $74.5 million in Q3 2021 to a low of -$37.3 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $22.7 million, with a median of $28.0 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: surged 669.7% in 2024, then crashed 169.59% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $31.8 million in 2021, then surged by 102.52% to $64.4 million in 2022, then crashed by 54.5% to $29.3 million in 2023, then surged by 82.94% to $53.6 million in 2024, then plummeted by 169.59% to -$37.3 million in 2025.
  • Per Business Quant, the three most recent readings for PODD's Capital Expenditures are -$37.3 million (Q4 2025), $48.5 million (Q3 2025), and $4.5 million (Q2 2025).